Full Text View
Tabular View
No Study Results Posted
Related Studies
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
This study has been terminated.
( Futility reasons after Independent Data Monitoring Committee interim analysis )
Study NCT00090025   Information provided by Helsinn Healthcare SA
First Received: August 19, 2004   Last Updated: January 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Biliary Tract Cancer
Additional conditions recognized in this trial
Biliary Tract Neoplasms
More general conditions related to this trial
Biliary Tract Diseases
Digestive System Diseases
Digestive System Neoplasms
Neoplasms
Neoplasms by Site
Interventions listed in this trial
becatecarin
5-Fluorouracil Plus Leucovorin
Additional drug interventions recognized in this trial
Fluorouracil
Leucovorin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Helsinn Healthcare SA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services